ストックスクリーナーアプリを入手
15.31
8.05%
-1.3409
Onconova Therapeutics Inc (ONTX) 最新ニュース
TRAWTraws Pharma Inc Stock Price and Quote - Finviz
Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer - Yahoo Finance
Q4 2025 Traws Pharma Inc Earnings Call Transcript - GuruFocus
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors - PR Newswire
Oncology Clinical Trials Market Size, Share, Growth, Analysis, 2034 - Straits Research
PI3K Inhibitors Clinical Trials Analysis 2025: Pipeline Analysis, Competitive Landscape, Emerging Therapies, Companies, and Future Outlook by DelveInsight - The Globe and Mail
Annovis Appoints Mark Guerin as Chief Financial Officer - citybiz
Rigosertib Shows Promise in EB-Associated Skin Cancer - Medscape
ONTX Stock Price, News & Analysis - Stock Titan
Huadong Medicine and Synerk to jointly develop siRNA drug - BioWorld MedTech
Onconova Therapeutics (NASDAQ: ONTXW)Share Price - intelligentinvestor.com.au
‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc. - orrick.com
Traws Pharma (TRAW) Stock Price, News & Analysis - MarketBeat
10 High-Volume Penny Stocks and Trading Strategies - StocksToTrade
Onconova and Trawsfynydd merge to form Traws Pharma By Investing.com - Investing.com UK
PI3K Inhibitors Clinical Trial Pipeline Experiences - GlobeNewswire
We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully - Yahoo Finance
Zim Doctor Appointed Chief Medical Officer in UK - ZimEye
Penny Stocks To Buy Now? 5 With Big News Today - PennyStocks.com
Onconova Therapeutics Touts Additional Positive Data For Rigosertib Monotherapy In Skin Cancer Setting - Yahoo Finance
Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors - citybiz
Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results on August 11, 2022 - The Globe and Mail
Corgi Onto 2X Daily ETF (ONTX-A) Stock Price and News - The Globe and Mail
Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug - Yahoo Finance
Targeting the Immune System and Beyond: The Potential for Safe and Durable Responses in Higher-Risk Myelodysplastic Syndromes with Immuno-Myeloid Therapy - EMJ
ONTX stock dives 16%, DVAX stock in green after clinical data - Kalkine Media
What's going on in today's pre-market session - ChartMill
Onconova Therapeutics Announces the Appointment of Mark Gelder, M.D., as Chief Medical Officer - GlobeNewswire
Why Onconova Therapeutics (ONTX) Stock Is Up Sharply - Market Realist
Onconova Therapeutics (ONTX) Stock Live Price, Chart & News - CoinCodex
ONTX Stock: Why Biopharma Onconova Therapeutics Is Shooting Higher Today - InvestorPlace
PrimoHoagies is on a roll, adding 21 stores, while Penn-backed Carisma raises cash to fight cancer - Inquirer.com
Novel CDK4/6 Inhibitor ON 123300 Receives Green Light to Move Into Phase 1 Testing in Relapsed/Refractory Advanced Cancers - OncLive
Onconova Therapeutics Stock Price Forecast. Should You Buy ONTX? - StockInvest.us
Onconova Therapeutics Appoints James J. Marino, JD, MBA as Chairman of the Board of Directors - citybiz
Onconova On The Edge After Phase III Rigosertib MDS Failure - Citeline News & Insights
Are These On Your List Of Penny Stocks To Trade This Week? - PennyStocks.com
Penny Stocks To Watch Before Next Week; 1 Up Over 370% In June 2020 - PennyStocks.com
Onconova Therapeutics Inc Files For Mixed Shelf Of Up To $150 Million - Reuters
ONTX Stock Price, Quote & Chart | ONCONOVA THERAPEUTICS INC (NASDAQ:ONTX) - ChartMill
Bucks County biopharm firm names new CEO - The Business Journals
Onconova Therapeutics Announces New CEO Appointment - Global Banking & Finance Review
Hedge Fund and Insider Trading News: Michael Novogratz, Ray Dalio, Onconova Therapeutics Inc. (ONTX), Cerecor Inc (CERC), Spirit of Texas Bancshares Inc (STXB), L3 Technologies Inc (LLL), and More - Insider Monkey
Onconova Therapeutics Announces License Agreement With Pint Pharma To Commercialize Rigosertib - Reuters
Onconova Therapeutics Announces Closing of $10 Million - GlobeNewswire
Onconova Therapeutics to Present at Biotech Showcase in January - GlobeNewswire
Onconova Therapeutics,Inc. (NASDAQ:ONTX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - marketexclusive.com
Onconova Therapeutics Announces Data on Improved - GlobeNewswire
Onconova Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewswire
Onconova Therapeutics Inc (ONTX): How Does It Impact Your Portfolio? - Yahoo Finance
Onconova Announces Two Presentations on Rigosertib in Myelodysplastic Syndromes at the ASH 2017 Annual Meeting - GlobeNewswire
Cellectar, Onconova partner on cancer drug conjugates - BioPharma Dive
Cellectar Biosciences enters into strategic collaboration with Onconova Therapeutics - Reuters
ONTEX Stock Price and Chart — EURONEXT:ONTEX - TradingView
ONTXOnconova Therapeutics Company Profile - StockInvest.us
Onconova Therapeutics, Inc. to Present at NobleCON13 - GlobeNewswire
Onconova Therapeutics, Inc. Announces Timing for Second Quarter 2016 Financial Results - GlobeNewswire
Onconova Informs Stockholders of Key Dates Related to Announced Rights Offering - GlobeNewswire
Onconova Presents Clinical Data from Oral Rigosertib and - GlobeNewswire
Onconova Announces Presentations Highlighting IV Rigosertib - GlobeNewswire
Inhibitor exhibits activity against myeloma - MDEdge
Onconova Announces Data Presentation From Phase 2 - GlobeNewswire
Onconova Therapeutics, Inc. to Present New Data on - GlobeNewswire
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2015 Financial Results - GlobeNewswire
Ben Franklin raises Rs40 crore from Asian Healthcare Fund and Ventureast - livemint.com
Onconova: Data Presentation From Combination Of Rigosertib And Azacitidine - RTTNews
Onconova To Present At Cowen Health Care Conference; Webcast At 11:20 AM ET - RTTNews
On the Boards - Inquirer.com
People in the News - Inquirer.com
Baxter 3Q earnings meet Wall Street estimates - CNBC
Onconova Presents Positive Clinical Trial Results for Radiation Injury Protector Ex-RAD® - CNBC
Baxter to help Onconova Therapeutics develop experimental cancer drug - Crain's Chicago Business
Onconova to seek US nod for trials on cancer drug - The Economic Times
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):